Article
Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping.
Journal of clinical pharmacology - 1 Sept 2004
Kim Myong-Jin, Nafziger Anne N, Zhang Yanhua, Sellers Edward M, Gaedigk Andrea, Bertino Joseph S
Abstract excerpt
To determine if dose dependency occurs with 2 weight-based single doses of omeprazole in a phenotyping study, as well as to quantitate 3-month intraindividual variability of CYP2C19 activity, 24 Caucasian subjects with body weights from 45 to 66 kg and 67 to 90 kg received single oral 30-mg and 40-mg doses of omeprazole, respectively. Female subjects were phenotyped during the mid-follicular and mid-luteal phases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
